Cargando…

Intellectual disability and antipsychotics

INTRODUCTION: Intellectual disability is a condition of cognitive impairment and deficit in adaptive skills. Mental illness is frequent in people with intellectual disability. As a result antipsychotics are often prescribed to treat not only mental illness but also problem behaviors. OBJECTIVES: Per...

Descripción completa

Detalles Bibliográficos
Autores principales: Iñiguez, I. Cuevas, Lietor, M.D.C. Molina
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cambridge University Press 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9475961/
http://dx.doi.org/10.1192/j.eurpsy.2021.1030
_version_ 1784790032367747072
author Iñiguez, I. Cuevas
Lietor, M.D.C. Molina
author_facet Iñiguez, I. Cuevas
Lietor, M.D.C. Molina
author_sort Iñiguez, I. Cuevas
collection PubMed
description INTRODUCTION: Intellectual disability is a condition of cognitive impairment and deficit in adaptive skills. Mental illness is frequent in people with intellectual disability. As a result antipsychotics are often prescribed to treat not only mental illness but also problem behaviors. OBJECTIVES: Perform a literature search about intellectual disability and antipsychotics. METHODS: A non-systematic literature review was performed on PubMed using the keywords “intellectual disability” and “antipsychotics”. All papers published between 2015 and 2020 were evaluated. RESULTS: A review of the literature reveals that antipsychotics are the most frequently prescribed psychotropic drugs in people with intellectual disability. However, results from the studies are ambiguous. Several studies showed that antipsychotics are effective in improving problem behaviours, nevertheless some recent studies showed no significant difference in the outcomes between antipsychotics and placebo CONCLUSIONS: Even though antipsychotics are prescribed in people with intellectual disability, evidence to support their use is lacking. In consequence, clinicians should consider the pharmacological approach as a part of an integrative treatment. Assessing adverse events, drug effects and the possibility of decreasing dose of antipsychotics is crucial.
format Online
Article
Text
id pubmed-9475961
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Cambridge University Press
record_format MEDLINE/PubMed
spelling pubmed-94759612022-09-29 Intellectual disability and antipsychotics Iñiguez, I. Cuevas Lietor, M.D.C. Molina Eur Psychiatry Abstract INTRODUCTION: Intellectual disability is a condition of cognitive impairment and deficit in adaptive skills. Mental illness is frequent in people with intellectual disability. As a result antipsychotics are often prescribed to treat not only mental illness but also problem behaviors. OBJECTIVES: Perform a literature search about intellectual disability and antipsychotics. METHODS: A non-systematic literature review was performed on PubMed using the keywords “intellectual disability” and “antipsychotics”. All papers published between 2015 and 2020 were evaluated. RESULTS: A review of the literature reveals that antipsychotics are the most frequently prescribed psychotropic drugs in people with intellectual disability. However, results from the studies are ambiguous. Several studies showed that antipsychotics are effective in improving problem behaviours, nevertheless some recent studies showed no significant difference in the outcomes between antipsychotics and placebo CONCLUSIONS: Even though antipsychotics are prescribed in people with intellectual disability, evidence to support their use is lacking. In consequence, clinicians should consider the pharmacological approach as a part of an integrative treatment. Assessing adverse events, drug effects and the possibility of decreasing dose of antipsychotics is crucial. Cambridge University Press 2021-08-13 /pmc/articles/PMC9475961/ http://dx.doi.org/10.1192/j.eurpsy.2021.1030 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/This is an Open Access article, distributed under the terms of the Creative Commons Attribution licence (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted re-use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Abstract
Iñiguez, I. Cuevas
Lietor, M.D.C. Molina
Intellectual disability and antipsychotics
title Intellectual disability and antipsychotics
title_full Intellectual disability and antipsychotics
title_fullStr Intellectual disability and antipsychotics
title_full_unstemmed Intellectual disability and antipsychotics
title_short Intellectual disability and antipsychotics
title_sort intellectual disability and antipsychotics
topic Abstract
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9475961/
http://dx.doi.org/10.1192/j.eurpsy.2021.1030
work_keys_str_mv AT iniguezicuevas intellectualdisabilityandantipsychotics
AT lietormdcmolina intellectualdisabilityandantipsychotics